Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3044043014 | Bruton's tyrosine kinase inhibitor (substance) | en | Fully specified name | Inactive | Entire term case sensitive (core metadata concept) | SNOMED CT core |
| 3044144018 | Bruton's tyrosine kinase inhibitor | en | Synonym (core metadata concept) | Inactive | Entire term case sensitive (core metadata concept) | SNOMED CT core |
| 3520628019 | Non-specific protein-tyrosine kinase inhibitor | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3520705011 | Substance with non-specific protein-tyrosine kinase inhibitor mechanism of action (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3520877013 | Substance with non-specific protein-tyrosine kinase inhibitor mechanism of action | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Non-specific protein-tyrosine kinase inhibitor | Is a | Protein-tyrosine kinase inhibitor | true | Inferred relationship | Some | ||
| Non-specific protein-tyrosine kinase inhibitor | This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. | Non-specific protein-tyrosine kinase inhibitor (disposition) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Ibrutinib (substance) | Is a | True | Non-specific protein-tyrosine kinase inhibitor | Inferred relationship | Some | |
| Acalabrutinib | Is a | True | Non-specific protein-tyrosine kinase inhibitor | Inferred relationship | Some | |
| Non-specific protein-tyrosine kinase inhibitor-containing product | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | True | Non-specific protein-tyrosine kinase inhibitor | Inferred relationship | Some | 1 |
| Zanubrutinib | Is a | True | Non-specific protein-tyrosine kinase inhibitor | Inferred relationship | Some | |
| Pirtobrutinib (substance) | Is a | True | Non-specific protein-tyrosine kinase inhibitor | Inferred relationship | Some | |
| Acalabrutinib maleate | Is a | True | Non-specific protein-tyrosine kinase inhibitor | Inferred relationship | Some |
This concept is not in any reference sets
FHIR